Profiting Off Breast Cancer: Eli Lilly Closes The Loop

In 2008, Eli Lilly purchased Posilac, Monsanto’s controversial hormone that is used to boost milk production in cows. You know it better at rRBGH. This artificial hormone used to boost milk production in cows has been linked to breast cancer and other health issues. Eli Lilly acquired rBGH from Monsanto knowing that Monsanto’s own studies show milk from cows treated with rBGH/Posilac contains increased levels of IGF-1, a hormone linked to cancer.

If that's not disturbing enough, here's where it gets sick. Eli Lilly also sells cancer treatment drugs like Gemzar and breast cancer prevention drugs like Evista. Eli Lilly’s cancer drugs made $2,683,000,000 for the company in 2008.

Way to close that profit circle, Eli Lilly.

How's that for some National Breast Cancer Awareness? Oh, by the way, did you know that National Breast Cancer Awareness Month was started, in part, by the pharmaceutical division of what is now AstraZeneca? If we're going to make ourselves aware, we should be fully aware. Let's do something more than slapping pink ribbons on products, detracting from the real issues.

Some organizations that don't pinkwash:

The Breast Cancer Fund

Think Before You Pink